Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Interferon beta-1b 100mcg/ solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1a 30mcg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 5000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 25000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 50000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 10000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 3000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 18,000,000iu/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 25 millioniu/vial solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 18 millioniu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 10 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 3 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 5 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Injectable interferon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2a-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-n3 human leu 5000000unt/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 6miu/vial injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 9miu/vial injection solution 0.9mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 36000000iu/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 3miu/vial injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18000000iu/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 3miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1a 30mcg/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 150micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 120micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 50micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
PEG-intron redipen 80micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2b 10million iu/2mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon alfa-2a 18million iu/0.5mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 1million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 4.5million iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 5million units injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 10million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 30million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 3million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 9million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 18million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 3million iu/1mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferons 10million iu/1mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Peginterferon alfa-2a 180micrograms/mL injection 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ribavirin+interferon alpha-2b |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ribavirin 200mg capsule+interferon alpha-2b 3million iu/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon beta-1b 0.3mg powder for injection+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Angiogenin |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Platelet factor 4 |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interleukin |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Interferon |
Is a |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytokine agent (substance) |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactoferrin |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Platelet-derived growth factor (substance) |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tumour necrosis factor alpha |
Is a |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tumor necrosis factor beta |
Is a |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lymphotoxin |
Is a |
False |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tumour necrosis factor |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ancestim |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Transforming growth factor beta 1 |
Is a |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytokine-associated toxicity (disorder) |
Causative agent (attribute) |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
A rare systemic condition affecting patients undergoing chimeric antigen receptor (CAR) T-cell therapy and characterized by a systemic inflammatory response due to massive activation of leukocytes with subsequent cytokine release. It can present with a variety of signs and symptoms ranging from mild, flu-like symptoms (such as fever, fatigue, headache, rash, arthralgia, and myalgia) to severe life-threatening manifestations including vascular leakage, disseminated intravascular coagulation, shock, and multiple organ failure. Respiratory manifestations are common and range from cough and tachypnea to acute respiratory distress syndrome (ARDS). |
Causative agent (attribute) |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Protein kinase C activity assay (procedure) |
Component |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lymphokine assay |
Component |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mononuclear cell function assay (procedure) |
Component |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intracellular free calcium assay (procedure) |
Component |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cytokine therapy |
Direct substance |
True |
Cytokine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |